Baillie Gifford & Co
MR

Baillie Gifford & Co’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Baillie Gifford & Co’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,997,374
Closed -$136M – 205
2015
Q4 		$136M Sell
4,997,374
-4,277,624
-46% -$110M 0.24% 69
2015
Q3 		$203M Sell
9,274,998
-949,616
-9% -$24.2M 0.4% 60
2015
Q2 		$291M Buy
10,224,614
+326,147
+3% +$9.5M 0.52% 53
2015
Q1 		$271M Buy
9,898,467
+267,652
+3% +$7.37M 0.51% 56
2014
Q4 		$254M Buy
9,630,815
+406,766
+4% +$11.9M 0.51% 57
2014
Q3 		$278M Buy
9,224,049
+244,370
+3% +$7.57M 0.61% 52
2014
Q2 		$283M Sell
8,979,679
-7,354
-0.1% -$233K 0.61% 49
2014
Q1 		$291M Buy
8,987,033
+303,691
+3% +$10.6M 0.68% 46
2013
Q4 		$316M Buy
8,683,342
+277,372
+3% +$10.8M 0.75% 36
2013
Q3 		$327M Buy
8,405,970
+499,785
+6% +$20.1M 0.83% 32
2013
Q2 		$296M Buy
+7,906,185
New +$312M 0.9% 30

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Baillie Gifford & Co's MR Position: Q1 2016 in Review

Baillie Gifford & Co sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 4,997,374 shares — an estimated $136M sold.

Baillie Gifford & Co first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $327M in Q3 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Baillie Gifford & Co reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Baillie Gifford & Co sold 4,997,374 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $136M.
  • Baillie Gifford & Co first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Baillie Gifford & Co's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $327M in Q3 2013.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Baillie Gifford & Co's 13F filing for Q1 2016, filed 5 May 2016.